S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase‐dependent pathway

Overview of attention for article published in Journal of Leukocyte Biology, March 2008

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (71st percentile)
Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

patent: 4 patents

Citations

dimensions_citation: 251 Dimensions

Readers on

mendeley: 99 Mendeley
citeulike: 1 CiteULike

Summary Patents Dimensions citations

So far, Altmetric has seen 4 patents that reference this research output.

NOVEL COMPOUNDS USEFUL AS S100-INHIBITORS

Application KR-20170005868-A

Republic of Korea

N-(HETEROARYL)-SULFONAMIDE DERIVATIVES USEFUL AS S100-INHIBITORS

Application KR-20160006717-A

Republic of Korea

N-(HETEROARYL)-SULFONAMIDE DERIVATIVES USEFUL AS S100-INHIBITORS

Application WO-2014184234-A1

World Intellectual Property Organisation (WIPO)

INHIBITORS OF RECEPTOR FOR ADVANCED GLYCATION-END PRODUCTS (RAGE) FOR USE IN TREATING AND/O…

Application WO-2013153092-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.